Cytotoxicity screening and cytokine profiling of nineteen nanomaterials enables hazard ranking and grouping based on inflammogenic potential

References

• Abitbol T, Rivkin A, Cao Y, Nevo Y, Abraham E, Ben-Shalom T, et al. 2016. Nanocellulose, a tiny fiber with huge applications. Curr Opin Biotechnol 39:76–88.
   PubMed Web of Science ®Google Scholar
• Alcorn JF, Crowe CR, Kolls JK. 2010. TH17 cells in asthma and COPD. Annu Rev Physiol 72:495–516.
   PubMed Web of Science ®Google Scholar
• Antonelli A, Ferrari SM, Corrado A, Ferrannini E, Fallahi P. 2014. CXCR3, CXCL10 and type 1 diabetes. Cytokine Growth Factor Rev 25:57–65.
   PubMed Web of Science ®Google Scholar
• Arend WP. 2002. The balance between IL-1 and IL-1Ra in disease. Cytokine Growth Factor Rev 13:323–40.
   PubMed Web of Science ®Google Scholar
• Arts JH, Hadi M, Irfan MA, Keene AM, Kreiling R, Lyon D, et al. 2015. A decision-making framework for the grouping and testing of nanomaterials (DF4nanoGrouping). Regul Toxicol Pharmacol 71:S1–27.
   PubMed Web of Science ®Google Scholar
• Arts JH, Hadi M, Keene AM, Kreiling R, Lyon D, Maier M, et al. 2014. A critical appraisal of existing concepts for the grouping of nanomaterials. Regul Toxicol Pharmacol 70:492–506.
   PubMed Web of Science ®Google Scholar
• Bhattacharya K, Andón FT, El-Sayed R, Fadeel B. 2013. Mechanisms of carbon nanotube-induced toxicity: focus on pulmonary inflammation. Adv Drug Deliv Rev 65:2087–97.
   PubMed Web of Science ®Google Scholar
• Bhattacharya K, Mukherjee SP, Gallud A, Burkert SC, Bistarelli S, Bellucci S, et al. 2016. Biological interactions of carbon-based nanomaterials: from coronation to degradation. Nanomedicine 12:333–51.
   PubMed Web of Science ®Google Scholar
• Braakhuis HM, Oomen AG, Cassee FR. 2016. Grouping nanomaterials to predict their potential to induce pulmonary inflammation. Toxicol Appl Pharmacol 299:3–7.
   PubMed Web of Science ®Google Scholar
• Braakhuis HM, Park MV, Gosens I, De Jong WH, Cassee FR. 2014. Physicochemical characteristics of nanomaterials that affect pulmonary inflammation. Part Fibre Toxicol 11:18.
   PubMed Web of Science ®Google Scholar
• Catalán J, Ilves M, Järventaus H, Hannukainen KS, Kontturi E, Vanhala E, et al. 2015. Genotoxic and immunotoxic effects of cellulose nanocrystals in vitro. Environ MolMutagen 56:171–82.
   PubMed Web of Science ®Google Scholar
• Cho WS, Duffin R, Bradley M, Megson IL, MacNee W, Lee JK, et al. 2013. Predictive value of in vitro assays depends on the mechanism of toxicity of metal oxide nanoparticles. Part Fibre Toxicol 10:55.
   PubMed Web of Science ®Google Scholar
• Cho WS, Duffin R, Poland CA, Howie SE, MacNee W, Bradley M, et al. 2010. Metal oxide nanoparticles induce unique inflammatory footprints in the lung: important implications for nanoparticle testing. Environ Health tPerspect 118:1699–706.
   PubMed Web of Science ®Google Scholar
• Chow KT, Gale M. 2015. Snapshot: interferon signaling. Cell 163:1808–e1.
   Web of Science ®Google Scholar
• Cocchi F, DeVico AL, Garzino-Demo A, Arya SK, Gallo RC, Lusso P. 1995. Identification of RANTES, MIP-1α and MIP-1β as the major HIV-suppressive factors produced by CD8+ T cells. Science 270:1811–15.
   PubMed Web of Science ®Google Scholar
• Dekkers S, Oomen AG, Bleeker EA, Vandebriel RJ, Micheletti C, Cabellos J, et al. 2016. Towards a nanospecific approach for risk assessment. Regul Toxicol Pharmacol 80:46–59.
   PubMed Web of Science ®Google Scholar
• Durán N, Durán M, de Jesus MB, Seabra AB, Fávaro WJ, Nakazato G. 2016. Silver nanoparticles: a new view on mechanistic aspects on antimicrobial activity. Nanomedicine 12:789–99.
   PubMed Web of Science ®Google Scholar
• Fadeel B, Fornara A, Toprak MS, Bhattacharya K. 2015. Keeping it real: the importance of material characterization in nanotoxicology. Biochem Biophys Res Commun 468:498–503.
   PubMed Web of Science ®Google Scholar
• Farcal L, Andón FT, Di Cristo L, Rotoli BM, Bussolati O, Bergamaschi E, et al. 2015. Comprehensive in vitro toxicity testing of a panel of representative oxide nanomaterials: first steps towards an intelligent testing strategy. PLoS One 10:e0127174.
   PubMed Web of Science ®Google Scholar
• Glass CK, Saijo K. 2010. Nuclear receptor transrepression pathways that regulate inflammation in macrophages and T cells. Nat Rev Immunol 10:365–76.
   PubMed Web of Science ®Google Scholar
• Godwin H, Nameth C, Avery D, Bergeson LL, Bernard D, Beryt E, et al. 2015. Nanomaterial categorization for assessing risk potential to facilitate regulatory decision-making. ACS Nano 9:3409–17.
   PubMed Web of Science ®Google Scholar
• Götz AA, Vidal-Puig A, Rödel HG, de Angelis MH, Stoeger T. 2011. Carbon-nanoparticle-triggered acute lung inflammation and its resolution are not altered in PPARγ-defective (P465L) mice. Part Fibre Toxicol 8:28.
   PubMed Web of Science ®Google Scholar
• Hamilton JA. 2008. Colony-stimulating factors in inflammation and autoimmunity. Nat Rev Immunol 8:533–44.
   PubMed Web of Science ®Google Scholar
• Hanif Z, Ahmed FR, Shin SW, Kim YK, Um SH. 2014. Size- and dose-dependent toxicity of cellulose nanocrystals (CNC) on human fibroblasts and colon adenocarcinoma. Colloids Surf B Biointerfaces 119:162–5.
   PubMed Web of Science ®Google Scholar
• Hong C, Tontonoz P. 2008. Coordination of inflammation and metabolism by PPAR and LXR nuclear receptors. Curr Opin Genet Dev 18:461–7.
   PubMed Web of Science ®Google Scholar
• Huizar I, Malur A, Patel J, McPeek M, Dobbs L, Wingard C, et al. 2013. The role of PPARγ in carbon nanotube-elicited granulomatous lung inflammation. RespirRes 14:7.
   Web of Science ®Google Scholar
• Ihaka R, Gentleman RR. 1995. A language for data analysis and graphics. J. Comput. Graph Stat 5:299–314.
   Google Scholar
• Jiang C, Ting AT, Seed B. 1998. PPAR-γ agonists inhibit production of monocyte inflammatory cytokines. Nature 391:82–6.
   PubMed Web of Science ®Google Scholar
• Kang H, Mintri S, Menon AV, Lee HY, Choi HS, Kim J. 2015. Pharmacokinetics, pharmacodynamics and toxicology of theranostic nanoparticles. Nanoscale 7:18848–62.
   PubMed Web of Science ®Google Scholar
• Krämer A, Green J, Pollard J, Tugendreich S. 2014. Causal analysis approaches in Ingenuity Pathway Analysis. Bioinformatics 30:523–30.
   PubMed Web of Science ®Google Scholar
• Landsiedel R, Sauer UG, Ma-Hock L, Schnekenburger J, Wiemann M. 2014. Pulmonary toxicity of nanomaterials: a critical comparison of published in vitro assays and in vivo inhalation or instillation studies. Nanomedicine (Lond) 9:2557–85.
   PubMed Web of Science ®Google Scholar
• Li Y, Boraschi D. 2016. Endotoxin contamination: a key element in the interpretation of nanosafety studies. Nanomedicine (Lond) 11:269–87.
   PubMed Web of Science ®Google Scholar
• Lynch I, Weiss C, Valsami-Jones E. 2014. A strategy for grouping of nanomaterials based on key physico-chemical descriptors as a basis for safer-by-design NMs. Nano Today 9:266–70.
   Web of Science ®Google Scholar
• Medzhitov R. 2008. Origin and physiological roles of inflammation. Nature 454:428–35.
   PubMed Web of Science ®Google Scholar
• Mihalache R, Verbeek J, Graczyk H, Murashov V, van Broekhuizen P. 2017. Occupational exposure limits for manufactured nanomaterials, a systematic review. Nanotoxicology 11:7– 19.
   PubMed Web of Science ®Google Scholar
• Mukherjee SP, Lozano N, Kucki M, Del Rio-Castillo AE, Newman L, Vázquez E, et al. 2016. Detection of endotoxin contamination of graphene based materials using the TNF-α expression test and guidelines for endotoxin-free graphene oxide production. PLoS One 11:e0166816.
   PubMed Web of Science ®Google Scholar
• Naha PC, Bhattacharya K, Tenuta T, Dawson KA, Lynch I, Gracia A, et al. 2010. Intracellular localisation, geno- and cytotoxic response of polyN-isopropylacrylamide (PNIPAM) nanoparticles to human keratinocyte (HaCaT) and colon cells (SW 480). Toxicol Lett 198:134–43.
   PubMed Web of Science ®Google Scholar
• Nel AE, Malloy TF. 2017. Policy reforms to update chemical safety testing. Science 355:1016–18.
   PubMed Web of Science ®Google Scholar
• Nel AE, Nasser E, Godwin H, Avery D, Bahadori T, Bergeson L, et al. 2013. A multi-stakeholder perspective on the use of alternative test strategies for nanomaterial safety assessment. ACS Nano 7:6422–33.
   PubMed Web of Science ®Google Scholar
• Ogawa S, Lozach J, Benner C, Pascual G, Tangirala RK, Westin S, et al. 2005. Molecular determinants of crosstalk between nuclear receptors and Toll-like receptors. Cell 122:707– 21.
   PubMed Web of Science ®Google Scholar
• Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK. 1998. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 391:79– 82.
   PubMed Web of Science ®Google Scholar
• Rigamonti E, Chinetti-Gbaguidi G, Staels B. 2008. Regulation of macrophage functions by PPAR-alpha, PPAR-gamma and LXRs in mice and men. Arterioscler Thromb Vasc Biol 28:1050–9.
   PubMed Web of Science ®Google Scholar
• Roebben G, Rasmussen K, Kestens V, Linsinger TPJ, Rauscher H, Emons H, Stamm H. 2013. Reference materials and representative test materials: the nanotechnology case. J Nanopart Res 15:1455.
   Web of Science ®Google Scholar
• Röszer T. 2017. Transcriptional control of apoptotic cell clearance by macrophage nuclear receptors. Apoptosis 22:284–94.
   PubMed Web of Science ®Google Scholar
• Shaw SY, Westly EC, Pittet MJ, Subramanian A, Schreiber SL, Weissleder R. 2008. Perturbational profiling of nanomaterial biologic activity. Proc Natl Acad Sci USA 105:7387–92.
   PubMed Web of Science ®Google Scholar
• Vallhov H, Qin J, Johansson SM, Ahlborg N, Muhammed MA, Scheynius A, Gabrielsson S. 2006. The importance of an endotoxin-free environment during the production of nanoparticles used in medical applications. Nano Lett 6:1682–6
   PubMed Web of Science ®Google Scholar
• Welch JS, Ricote M, Akiyama TE, Gonzalez FJ, Glass CK. 2003. PPAR-γ and PPAR-δ negatively regulate specific subsets of lipopolysaccharide and IFN-γ target genes in macrophages. Proc Natl Acad Sci USA 100:6712–17.
   PubMed Web of Science ®Google Scholar
• Wiemann M, Vennemann A, Sauer UG, Wiench K, Ma-Hock L, Landsiedel R. 2016. An in vitro alveolar macrophage assay for predicting the short-term inhalation toxicity of nanomaterials. J Nanobiotechnol 14:16.
   PubMed Web of Science ®Google Scholar
• Xia T, Hamilton RF, Bonner JC, Crandall ED, Elder A, Fazlollahi F, et al. 2013. Interlaboratory evaluation of in vitro cytotoxicity and inflammatory responses to engineered nanomaterials: the NIEHS Nano GO Consortium. Environ Health tPerspect 121:683–90.
   PubMed Web of Science ®Google Scholar